Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 52

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 52
---
any specified period. According to our Amended and Restated Memorandum and Articles of Association, a director may be removed by an ordinary
resolution of our shareholders. An ordinary resolution to be passed at a general meeting of the shareholders requires the affirmative
vote of a simple majority of all votes which are cast by those shareholders entitled to vote who are present in person or by proxy at
such general meeting. Immediately after the offering, the two Class B shareholders, consisting of LTO Holdings Ltd. and Qingtian Holdings
Ltd, will own an aggregate of 8,500,000 ordinary shares, consisting of 7,500,000 Class A Ordinary Shares and 1,000,000 Class B Ordinary
Shares, representing [●]% of our total voting power of our outstanding ordinary shares. In cases where their interests are aligned
and they vote together, they could control the outcome of the matters submitted to shareholders for approval, including the removal of
any of the directors. Therefore, if the two Class B shareholders vote together against the removal of any director, you may not be able
to remove such director.

Living Homeopathy’s lack of effective internal controls over financial reporting may affect its ability to accurately report its financial results or prevent fraud, which may affect the market for and price of Living Homeopathy’s Class A Ordinary Shares.

To implement Section 404 of the Sarbanes-Oxley Act of 2002, the SEC adopted rules requiring public companies to include a report of management on the company’s internal control over financial reporting. Prior to filing the registration statement of which this prospectus is a part, Living Homeopathy was a private company with limited accounting personnel and other resources for addressing Living Homeopathy’s internal control over financial reporting. Living Homeopathy’s management has not completed an assessment of the effectiveness of Living Homeopathy’s internal control over financial reporting and its independent registered public accounting firm has not conducted an audit of Living Homeopathy’s internal control over financial reporting.

<div align='center'>27</div>

Living Homeopathy will be subject to the requirement that it maintains internal controls and that management performs periodic evaluation of the effectiveness of the internal controls. Effective internal control over financial reporting is important to prevent fraud. As a result, Living Homeopathy’s business, financial condition, results of operations and prospects, as well as the market for and trading price of the Class A Ordinary Shares, may be materially and adversely affected if Living Homeopathy does not have effective internal controls. Before this offering, Living Homeopathy was a private company with